Stay updated on SAGE-217 Safety in MDD Insomnia Clinical Trial

Sign up to get notified when there's something new on the SAGE-217 Safety in MDD Insomnia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SAGE-217 Safety in MDD Insomnia Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The NIH announcement about the terminology transition from “Artificial Intelligence” to “Super Intelligence” no longer appears at the top of the page.
    Difference
    1%
    Check dated 2026-11-07T12:26:02.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The site revision in the footer changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error rather than study details.
    Difference
    0.2%
    Check dated 2026-10-31T13:12:50.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A sitewide NIH notice appears above the page, announcing a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T15:48:05.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2. The page still displays a 403 error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-17T15:37:14.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The revision identifier in the footer changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T16:14:15.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study record details, blocking access to core information and related documents about the trial.
    Difference
    19%
    Check dated 2026-09-19T18:46:00.000Z thumbnail image

Stay in the know with updates to SAGE-217 Safety in MDD Insomnia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SAGE-217 Safety in MDD Insomnia Clinical Trial page.